Philips and Inspirata, Inc. partner to bring an end-to-end digital pathology workflow to U.S. cancer centers


Managed service approach and advanced algorithms aim to drive adoption by eliminating barriers to entry

March 19, 2015

Eindhoven, The Netherlands and Tampa, USA – Royal Philips (NYSE:PHG, AEX:PHIA) and Inspirata, Inc. today announced that they have entered into a joint development agreement to advance digital pathology through the development of advanced image analytics and automated workflows available as a Solution-as-a-Service delivery model. Focusing initially on the needs of U.S. cancer centers, the creation of improved insights and algorithms will help pathologists in better informed decision making.

 

“The advancement of digital pathology offers pathologists the opportunity for improved working experience that can be an important next step toward improving diagnosis and better and more accurate treatment,” said Perry van Rijsingen, general manager of Philips Digital Pathology Solutions. “Reducing the investment required by institutions – particularly high-volume, high-touch ones like cancer centers – opens the door for more patients to benefit from this level of care and attention.”

 

Built on the foundation of Philips’ innovation and experience in clinical informatics, Inspirata’s managed service model will supply the necessary IT infrastructure, services and resources for a digital program and eliminate capital expenditures related to the transition.

 

“Infrastructure requirements for digital pathology are enormous,” said Satish Sanan, Chairman and CEO of Inspirata. “We’re talking petabytes of data, which can exceed the storage requirements of all other clinical systems combined. Removing this impediment by integrating everything needed for accelerated department-wide implementation and long-term support encourages the adoption of professional services to operationalize and sustain a highly functional digital pathology environment.”

 

Philips (Booth #502) and Inspirata (Booth #501) will both be exhibiting at the 2015 USCAP Annual Conference in Boston, taking place March 21-27. For more information, stop by the booth or visit http://www.research.philips.com/initiatives/digitalpathology/.

For further information, please contact:

Hans Driessen, Corporate Communications
Philips Digital Pathology Solutions
Tel: +31 6 10 610 417,
E-mail: hans.driessen@philips.com

 

Marjorie Bulone
Inspirata, Inc.
Tel: 727 215 8141
E-mail: mbulone@inspirata.com 

.

About Inspirata, Inc.

Inspirata, Inc. provides a cancer diagnostics solution that digitizes and automates the entire pathology workflow using a unique, “solution as a service” delivery model. This comprehensive solution includes workflow automation and computer-aided cancer detection and diagnostic tools. Inspirata’s solution also includes a suite of algorithms to extract relevant image-based information from digitized histology specimens for use as supplemental aids to assist pathologists with diagnoses and to aid in the prediction of disease progression and therapeutic responses. For more information, please visit www.inspirata.com or contact info@inspirata.com.

.

About Royal Philips:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 105,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

.